• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMÉRIEUX ESPAÑA GRANADA AGAR; GRANADA¿ AGAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMÉRIEUX ESPAÑA GRANADA AGAR; GRANADA¿ AGAR Back to Search Results
Model Number 43712
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
An internal biomérieux investigation was performed.The clinical strain was not able to survive; the investigation was performed with the strains from the biomerieux quality control lab collection due to concern as to how the clinical strains were collected and transported, directly on gran medium.After primary isolation either on schaedler broth agar supplemented with vitek® knowledge base 3 or cos medium described: no anomalies were observed during a review of the manufacturing records (device history record).Microbiological control prior its releasing the batch were as expected and within current specifications; therefore, based on the inspection of the batch record, the root cause at the manufacturing level cannot be determined.The clinical control strain were inoculated under regular qc control using s.Agalactiae atcc 12386, which are identified as gbs strains as the strain from the customer is not available anymore.Likewise, the retention sample was tested in parallel with other batches manufactured at different times from the manufacturing date, in order to determine if the defect of the performance seen by customer is reproduced in another batch.It is important to note that the complaint batch expired as of 12may2017.Furthermore, columbia blood agar, used as control to ensure the recovery and beta-hemolytic reaction of all target strains is intended.Reading was performed after incubation under aerobic conditions at 33- 37 º c for 18-24 hours.After incubation, in all cases (even with the complaint batch that had already expired), results were within specifications and the intensity of coloration was as expected for all strains tested, typical orange pigment developed in all cases.In conclusion, s.Agalactiae atcc 12386, which is the atcc used in routine qc, remains good with positive and it is not related to the product itself.Further investigation is not possible due to the need for the customer's strain in the product information, it is already defined in the methods limitation that certain strains may not produce typical color.Some strains of s.Agalactiae may not produce typical colonies, particularly non-hemolytic strains (2.3 %).
 
Event Description
A customer in (b)(6) notified biomérieux of a discrepant result associated with granada¿ agar (reference 43712) involving an external quality control sample (cqe lab quality).The customer reported obtaining a white colony on the plate.The customer reported two (2) patient strains with this problem.The specimen from the first patient was inoculated directly on the agar plate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GRANADA AGAR
Type of Device
GRANADA¿ AGAR
Manufacturer (Section D)
BIOMÉRIEUX ESPAÑA
isaac newton, 6
tres cantos
madrid, 28760
SP  28760
Manufacturer (Section G)
BIOMÉRIEUX ESPAÑA
isaac newton, 6
tres cantos
madrid, 28760
SP   28760
Manufacturer Contact
ellen weltmer
595 anglum road
saint louis, MO 63042
MDR Report Key6671114
MDR Text Key78783671
Report Number3002769706-2017-00150
Device Sequence Number1
Product Code JSO
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
CI EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial
Report Date 06/27/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/02/2017
Device Model Number43712
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/30/2017
Initial Date FDA Received06/27/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/21/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-